SCHEMBL586754

SCHEMBL586754

N#CC(=C1CCCCC1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.49
RAB9A P51151 8/20 0.49
SMN1; SMN2 Q16637 6/20 0.49
MAPT P10636 5/20 0.49
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
RECQL P46063 2/20 0.49
HPGD P15428 4/20 0.43
CHRNB2 P17787 1/20 0.42
CHRNA4 P43681 1/20 0.42
ALDH1A1 P00352 6/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
TSHR P16473 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
HSD17B10 Q99714 2/20 0.42
HCRTR1 O43613 1/20 0.42
USP2 O75604 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL28160719 1.00 NPC1 (0.49) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL3210075 0.98 NPC1 (0.50) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
Phenylethyl Alcohol SCHEMBL28050164 0.86 TDP1 (0.47) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL28626730 0.82 CYP19A1 (0.43) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL2564307 0.81 NPC1 (0.51) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL29090498 0.81 RAB9A (0.51) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL31512564 0.81 OGG1 (0.39) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL2402920 0.81 ALDH1A1 (0.46) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL1472474 0.81 CHRNB2 (0.41) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL29172164 0.80 ALDH1A1 (0.42) NPC1RAB9ASMN1; SMN2MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4214303-B1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2026-05-06 EP claimed
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation GIVAUDAN SA (CH) 2026-03-31 US claimed
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 US claimed
EP-4695016-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Givaudan SA (CH) 2026-02-18 EP claimed
US-12522786-B2 Organic compounds GIVAUDAN SA (CH) 2026-01-13 US claimed
EP-4655373-A1 BIODEGRADABLE PERFUME COMPOSITION Givaudan SA (CH) 2025-12-03 EP claimed
WO-2025202258-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2025-10-02 WO claimed
US-12404479-B2 Laundry detergent composition containing graft copolymer and benefit agent THE PROCTER & GAMBLE COMPANY (US) 2025-09-02 US claimed
US-12384990-B2 Treatment compositions comprising plant rosin material and certain perfume raw materials THE PROCTER & GAMBLE COMPANY (US) 2025-08-12 US claimed
EP-4581114-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Novozymes A/S (DK) 2025-07-09 EP claimed
WO-2008055372-A1 MALODOR COUNTERACTING COMPOSITIONS GIVAUDAN SA (CH) 2008-05-15 WO claimed
WO-2007054177-A1 FRAGRANT CONSUMER PRODUCTS COMPRISING OXIDIZING AGENTS HENKEL AG & CO. KGAA (DE) 2007-05-18 WO claimed
WO-2007030961-A2 TOPICAL COMPOSITIONS FOR REDUCING SKIN IRRITATION GIVAUDAN SA (CH) 2007-03-22 WO claimed
US-20050245407-A1 Fragrance composition KAO CORPORATION (JP) 2005-11-03 US claimed
CN-1674862-A Perfume composition KAO CORP (JP) 2005-09-28 CN claimed
EP-1552814-A1 FRAGRANCE COMPOSITION Kao Corporation (JP) 2005-07-13 EP claimed
EP-0858498-B1 NITRILE GIVAUDAN SA (CH) 2001-09-12 EP claimed
US-6069125-A PERFUMED ARTICLE SUCH AS EAUX DE COLOGNE, LOTIONS, SHAMPOOS, SOAPS, POWDERS, COSMETICS, DEODORANTS, DETERGENTS, TEXTILE CONDITIONERS AND BLEACHING AGENTS CONTAINING AN OLFACTORILY EFFECTIVE AMOUNT OF CYCLOHEXYLIDENE-PHENYLACETONITRILE GIVAUDAN ROURE (INTERNATIONAL) SA (CH) 2000-05-30 US claimed
EP-0858498-A1 NITRILE GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1998-08-19 EP claimed
WO-1997016512-A1 NITRILE GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1997-05-09 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation CUTA, EXOC1, EXOSC10 NPC1 3012/4885RAB9A 4118/4885SMN1; SMN2 3273/4885
US-12559703-B2 Fragrance composition DHCR24, OPRD1, OR10J3 NPC1 3108/4885RAB9A 4290/4885SMN1; SMN2 3767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.